Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J L TrouilletC Gibert

Abstract

We sought to determine the epidemiological characteristics of patients in an intensive care unit (ICU) who developed ventilator-associated pneumonia (VAP) caused by piperacillin-resistant Pseudomonas aeruginosa (PRPA; n=34) or piperacillin-susceptible P. aeruginosa (PSPA; n=101). According to univariate analysis, the factors associated with the development of PRPA VAP were presence of an underlying fatal medical condition, immunocompromised status, longer previous hospital stay, less-severe illness at the time of ICU admission, duration of mechanical ventilation before onset of VAP, number of classes of antibiotic received, and previous exposure to imipenem or fluoroquinolone. Multivariate logistic regression analysis identified the following significant independent factors: presence of an underlying fatal medical condition (odds ratio [OR], 5.6), previous fluoroquinolone use (OR, 4.6), and initial disease severity (OR, 0.8). We concluded that the clinical characteristics of patients who develop PRPA VAP differ from those of patients who develop PSPA VAP. Restricted fluoroquinolone use is the sole independent risk factor for PRPA VAP that is open to medical intervention.

References

Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Aug 1, 1974·The American Journal of Medicine·C W ZwillichT L Petty
Mar 1, 1994·American Journal of Respiratory and Critical Care Medicine·G R BernardR Spragg
Jul 1, 1995·American Journal of Respiratory and Critical Care Medicine·J ChastreC Gibert
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·J RelloR Rodriguez-Roisin
Dec 22, 1993·JAMA : the Journal of the American Medical Association·J R Le GallF Saulnier
Apr 1, 1996·Chest·S Crouch BrewerK V Leeper
Dec 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J ChastreJ L Trouillet
Apr 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R C Spencer
Feb 26, 1998·American Journal of Respiratory and Critical Care Medicine·J L TrouilletC Gibert
Feb 2, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·N S CrowcroftR Mertens
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A HarrisY Carmeli
Sep 29, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·E A ArrudaA S Levin
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·M J BontenE E Stobberingh
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S HarbarthD Pittet

❮ Previous
Next ❯

Citations

Feb 27, 2007·Intensive Care Medicine·Charles-Edouard LuytJean Chastre
Oct 23, 2013·Intensive Care Medicine·Jordi RelloThiago Lisboa
Jul 2, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M J DinubileJ P Quinn
Jun 1, 2006·The American Journal of Medicine·John E McGowan
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter K LindenDavid Paterson
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elisabeth ParamythiotouAntoine Andremont
Dec 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael S Niederman
Aug 9, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter K Linden, David L Paterson
Aug 10, 2006·Surgical Infections·Jean Chastre
Feb 11, 2003·Critical Care Medicine·George H Karam, Michael S Niederman
Aug 30, 2005·Antimicrobial Agents and Chemotherapy·Simone Aranha NouérBeatriz Meurer Moreira
Nov 2, 2004·American Journal of Respiratory and Critical Care Medicine·Harald J van LoonMarc J M Bonten
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Mar 21, 2006·Beilstein Journal of Organic Chemistry·Babak Kaboudin, Fatemeh Farjadian
Apr 13, 2011·Critical Care : the Official Journal of the Critical Care Forum·Catherine KaminskiUNKNOWN OUTCOMEREA study group
Jul 1, 2005·Critical Care : the Official Journal of the Critical Care Forum·Jordi Rello
May 19, 2007·Critical Care : the Official Journal of the Critical Care Forum·Ali A El SolhCorey R Mankowski
Jun 17, 2008·Critical Care : the Official Journal of the Critical Care Forum·James J Rahal
May 21, 2008·Critical Care : the Official Journal of the Critical Care Forum·Christiane ForestierChristophe De Champs
Aug 2, 2007·The Annals of Pharmacotherapy·Katherine Yang, B Joseph Guglielmo
Jan 18, 2006·Treatments in Respiratory Medicine·Gunnar I Andriesse, Jan Verhoef
Jul 14, 2011·Emerging Infectious Diseases·Ehimare AkhabueEbbing Lautenbach
Feb 2, 2013·Intensive Care Medicine·Mario TumbarelloMassimo Antonelli
Nov 28, 2014·Intensive Care Medicine·Girish B Nair, Michael S Niederman
May 4, 2004·Current Medical Research and Opinion·Robert P RappJohn A Armitstead
Jul 9, 2013·Critical Care Clinics·Girish B Nair, Michael S Niederman
Nov 19, 2014·Critical Care : the Official Journal of the Critical Care Forum·Charles-Edouard LuytJean Chastre
Nov 16, 2010·Travel Medicine and Infectious Disease·Fahmi Yousef KhanEman Almaslamani
Jun 15, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G M Rossolini, E Mantengoli
Jan 26, 2010·Medicina intensiva·P M OlaecheaP Luque
Apr 28, 2009·Infectious Disease Clinics of North America·Evelina Tacconelli, Maria A Cataldo
Jul 16, 2008·Burns : Journal of the International Society for Burn Injuries·Amen Allah MessadiBen Redjeb Saida
Dec 8, 2004·Critical Care Clinics·Lawrence Shulman, David Ost

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

American Journal of Respiratory and Critical Care Medicine
J L TrouilletC Gibert
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Elisabeth ParamythiotouAntoine Andremont
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Anthony D HarrisMary-Claire Roghmann
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
E A ArrudaAnna S Levin
© 2022 Meta ULC. All rights reserved